Onychomycosis: Clinical Trials

134 trials for Onychomycosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

95 completed, 25 unknown, 5 recruiting, 3 not yet recruiting. 39 Phase 2, 36 Not applicable, 21 Phase 3, 17 Phase 1, 16 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 239Completed 30, Unknown 6, Active not recruiting 1, Recruiting 1, Suspended 1
Not applicable36Completed 20, Unknown 9, Recruiting 3, Not yet recruiting 2, Active not recruiting 1, Withdrawn 1
Phase 321Completed 14, Unknown 5, Terminated 2
Phase 117Completed 15, Recruiting 1, Unknown 1
Phase 416Completed 13, Unknown 3

Follow Onychomycosis: new trials by email Literature Review of Onychomycosis trials Research Report on Onychomycosis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Systemic Antifungal Plus Q-Switched Nd:YAG Laser for Onychomycosis
Terbinafine, Q-switched Nd:YAG laser - Onychomycosis
Not applicableNot yet recruitingAssiut University972026-10-102026-10-09
URGO MICKAEL Filmogel, Topical Treatment of Onychomycosis
URGO MICKAEL Filmogel - Onychomycosis of Toenail
Not applicableRecruitingCEN Biotech542026-01-282026-09-22
Fractional CO₂ Laser or 40% Urea With Topical Fluconazole Microemulsion in Onychomycosis
"Fractional CO2 laser" and "topical fluconazole microemulsion", "Urea 40%" and "topical fluconazole microemulsion" - Onychomycosis
Not applicableNot yet recruitingAssiut University402025-06-012025-06-29
Study in Patients With Onychomycosis Treated With Mycoclear® and Ciclopirox
Onychomycosis of Toenails
Not yet recruitingUniversity of Bologna802025-05-302025-05-20
Safety, Tolerability and Efficacy of Trichostatin A in Patients With Mild to Severe Onychomycosis
Trichostatin A - Onychomycosis of Toenail
Phase 2Active not recruitingVanda Pharmaceuticals502025-05-052026-02-04
Exploring Different Dose-frequency Home Photodynamic Therapy Protocols Using a Novel Home-targeted LED Device for Onychomycosis
Photodynamic Therapy with Conventional Methylene Blue, urea 40% cream - Onychomycosis of Toenails, Onychomycosis of Fingernail
Not applicableActive not recruitingChulalongkorn University502025-01-132026-05-12
Evaluation of a Combination of Two Medical Devices and One Device Use in the Treatment of Toenail Onychomycosis
Sérum PURIFIANT, Sérum PURIFIANT in association Sérum BOOSTER - Onychomycosis
Not applicableCompletedSwiss Footcare Laboratories - Poderm Professional442024-11-122026-06-24
CLINICAL INVESTIGATION FOR THE EVALUATION OF EFFICACY AND SAFETY OF TWO PRODUCTS FOR THE TREATMENT OF ONYCHOMYCOSIS
Enriched, Loceryl 5% - Onychomycosis
Not applicableRecruitingOystershell NV882024-10-302025-09-03
Isotretinoin Versus Excimer Light an Adjuvant in Treating Onychomycosis
ISOtretinoin 10 MG, excimer light, Itraconazole 200 mg - Onychomycosis
Phase 1RecruitingZagazig University362024-07-122026-04-23
A Study of ATB1651 in Adults With Mild to Moderate Onchomycosis
ATB1651-102- Cohort 1, ATB1651-102- Cohort 2, ATB1651-102- Cohort 3 - Onychomycosis
Phase 2RecruitingAmtixBio Co., Ltd.1202024-07-012025-02-19
Clinical Investigation for the Evaluation of Efficacy and Safety of Two Medical Devices for Onychomycosis Treatment
Forte, Active Cover Light, Loceryl - Onychomycosis
Not applicableUnknownOystershell NV1322024-03-012024-02-12
A Trial to Evaluate the Safety and Efficacy of DBI-001 Gel, DBI-002 Gel, and Aqueous Gel in Subjects With Onychomycosis
DBI-001, DBI-002, Aqueous Gel - Onychomycosis
Phase 2SuspendedDermBiont, Inc.602023-11-012023-09-07
Evaluation of the Effectiveness of Nail Genesis DLSO Product for Onychomycosis
Nail Genesis DLSO Product, Nail Genesis DLSO Product (vehicle only) - Distal Lateral Subungual Onychomycosis, Onychomycosis
Not applicableUnknownNail Genesis LLC3382023-10-012023-12-08
Diode Laser and Photodynamic Therapy Vs. Ciclopirox.
Diode laser combined with photodynamic-red laser therapy by RapidoPodia Laser Diodo®, Ciclopirox Hydroxypropyl Chitosan (HPCH) Nail Lacquer - Onychomycosis
Phase 4UnknownUniversidad Complutense de Madrid262023-09-012023-05-10
Pilot Study of Swift Microwave Device for Onychomycosis
Swift Microwave treatment - weekly x 4wks, Swift Microwave treatment - Every other week x 4wks, Swift Microwave treatment - Every other week x 24wks - Onychomycosis of Toenail
Phase 1 / Phase 2CompletedMediprobe Research Inc.392023-03-272024-11-18
Infrared Bioeffect System for the Treatment of Onychomycosis
infrared thermotherapy instrument - Hyperthermia
Not applicableUnknownGao Xinghua602023-02-242023-09-14
Effectiveness and Safety of Nailner Brush 2in1 in Onychomycosis
topical treatment - Onychomycosis
Not applicableCompletedKaro Pharma AB502022-07-282023-10-04
Mycosis Culture Collection From Dermatological Isolated
Terbinafine Topical Gel, Itraconazole 200 mg, Terbinafine 250 mg - Onychomycosis, Resistant Infection
UnknownUniversity of Rome Tor Vergata2002022-07-202024-05-08
Radiofrequency in Onychomycosis
Non ablative radiofrequency - Onychomycosis
Not applicableUnknownCairo University202022-07-012022-05-25
Lasers in Onychomycosis
Laser - Onychomycosis
Not applicableUnknownCairo University402022-06-252022-06-13

Showing 20 of 134. Sign in to see all of them.

Narrower conditions

Foot Dermatoses (8)  ·  Mycoses (6)  ·  Keratoderma, Palmoplantar, Epidermolytic (3)  ·  Nails, Malformed (3)  ·  Onycholysis (3)  ·  Diabetes Mellitus, Type 2 (2)  ·  Nail Diseases (2)  ·  Tinea Pedis (2)  ·  Twenty-Nail Dystrophy (2)  ·  Yellow Nail Syndrome (2)  ·  Acne Vulgaris (1)  ·  Cellulitis (1)  ·  Dermatomycoses (1)  ·  Diabetes Mellitus (1)

Broader conditions

Bacterial Infections and Mycoses (134)  ·  Skin Diseases (134)  ·  Skin Diseases, Infectious (134)  ·  Skin and Connective Tissue Diseases (134)  ·  Dermatomycoses (133)  ·  Infections (133)  ·  Tinea (133)  ·  Nail Diseases (132)  ·  Mycoses (128)  ·  Foot Diseases (10)  ·  Pathological Conditions, Signs and Symptoms (7)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)  ·  Genetic Diseases, Inborn (3)  ·  Keratoderma, Palmoplantar (3)  ·  Keratoderma, Palmoplantar, Diffuse (3)

Interventions

Terbinafine (18)  ·  amorolfine (9)  ·  tavaborole (7)  ·  Itraconazole (6)  ·  Solutions (5)  ·  Lasers (4)  ·  efinaconazole (4)  ·  Ciclopirox (3)  ·  Urea (3)  ·  Antifungal Agents (2)  ·  Keratolytic Agents (2)  ·  Tablets (2)  ·  albaconazole (2)  ·  posaconazole (2)  ·  Amphotericin B (1)

Sponsors

Pfizer (11)  ·  Erchonia Corporation (4)  ·  Galderma R&D (4)  ·  Mahidol University (4)  ·  Moberg Pharma AB (4)  ·  Stiefel, a GSK Company (4)  ·  Dow Pharmaceutical Sciences (3)  ·  Oystershell NV (3)  ·  AmtixBio Co., Ltd. (2)  ·  Assiut University (2)  ·  Cairo University (2)  ·  Celtic Pharma Development Services (2)  ·  Chulalongkorn University (2)  ·  Hallux, Inc. (2)  ·  Meiji Seika Pharma Co., Ltd. (2)

Countries

United States (67)  ·  Canada (14)  ·  Germany (8)  ·  France (6)  ·  Iceland (6)  ·  Thailand (6)  ·  Mexico (4)  ·  Poland (4)  ·  Belgium (3)  ·  Brazil (3)  ·  Czechia (3)  ·  Dominican Republic (3)  ·  Italy (3)  ·  Spain (3)  ·  Egypt (2)

Top investigators

Eduardo Tschen, MD (2)  ·  Joanne Fraser, PhD (2)  ·  Kent Allenby, MD (2)  ·  Kerry Zang, DPM (2)  ·  Maurizio Caserini, MD (2)  ·  Phoebe Rich, MD (2)  ·  Steven Herrmann, MD (2)  ·  Aditya Gupta, MD,PhD (1)

Results publications

PMID 25007364, PMID 10233295, PMID 10642676, PMID 14723731, PMID 20347657, PMID 21820203, PMID 21967490, PMID 22236569, PMID 22453588, PMID 22976905, PMID 23278851, PMID 23377392, PMID 23416171, PMID 23884486, PMID 24079583, PMID 24173203, PMID 25013957, PMID 25357174, PMID 25639524, PMID 25872590, PMID 26471716, PMID 27799043, PMID 27815659, PMID 28670355, PMID 30811142, PMID 32421854, PMID 39158295, PMID 39624747, PMID 41024682

NIH funding

2015 (2), 2008 (1)